Exelixis, Inc.EXELNASDAQ
Loading
SG&A Expense Growth Recovery in ProgressRecovering
Percentile Rank29
3Y CAGR-28.0%
5Y CAGR-28.3%
Studio
Year-over-Year Change

Year-over-year SG&A expense growth

3Y CAGR
-28.0%/yr
vs -16.3%/yr prior
5Y CAGR
-28.3%/yr
Consistent
Acceleration
-11.7pp
Decelerating
Percentile
P29
Within normal range
vs 5Y Ago
0.2x
Contraction
Streak
1 yr
Consecutive growthRecovering
PeriodValue
20255.40%
2024-9.32%
202318.02%
202214.47%
202136.94%
202028.53%
201910.60%
201829.52%
201737.18%
2016102.68%